Histological response to radiotherapy is an early event in myxoid liposarcoma

[1]  A. B. Hassan,et al.  Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2021, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  R. Maestro,et al.  Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells , 2021, Cancers.

[3]  R. Haas,et al.  A moderate dose of preoperative radiotherapy may improve resectability in myxoid liposarcoma. , 2021, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  H. V. van Boven,et al.  Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial. , 2020, JAMA oncology.

[5]  J. Desai,et al.  Characterising the immune microenvironment in liposarcoma, its impact on prognosis and the impact of radiotherapy , 2020, Journal of surgical oncology.

[6]  T. Illidge,et al.  Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations , 2020, Radiation Oncology.

[7]  J. Wunder,et al.  Impact of perioperative chemotherapy and radiotherapy in patients with primary extremity soft tissue sarcoma: retrospective analysis across major histological subtypes and major reference centres. , 2018, European journal of cancer.

[8]  F. Ağaoğlu,et al.  Neoadjuvant radiotherapy for myxoid liposarcomas: Oncologic outcomes and histopathologic correlations , 2017, Acta orthopaedica et traumatologica turcica.

[9]  C. Raut,et al.  Histologic Appearance After Preoperative Radiation Therapy for Soft Tissue Sarcoma: Assessment of the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group Response Score. , 2017, International journal of radiation oncology, biology, physics.

[10]  A. Shinagare,et al.  Neoadjuvant radiation in primary extremity liposarcoma: correlation of MRI features with histopathology , 2016, European Radiology.

[11]  F. Wenz,et al.  Cellular Pathways in Response to Ionizing Radiation and Their Targetability for Tumor Radiosensitization , 2016, International journal of molecular sciences.

[12]  Kevin J. Harrington,et al.  The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence , 2015, Nature Reviews Cancer.

[13]  Y. Fujiwara,et al.  Tumour-associated macrophages correlate with poor prognosis in myxoid liposarcoma and promote cell motility and invasion via the HB-EGF-EGFR-PI3K/Akt pathways , 2015, British Journal of Cancer.

[14]  R. Baskar,et al.  Biological response of cancer cells to radiation treatment , 2014, Front. Mol. Biosci..

[15]  C M Galmarini,et al.  Mode of action of trabectedin in myxoid liposarcomas , 2014, Oncogene.

[16]  A. Lazar,et al.  Extensive adipocytic maturation can be seen in myxoid liposarcomas treated with neoadjuvant doxorubicin and ifosfamide and pre-operative radiation therapy , 2012, Clinical Sarcoma Research.

[17]  R. Grimer,et al.  Prognostic Factors and Metastatic Patterns in Primary Myxoid/Round-Cell Liposarcoma , 2011, Sarcoma.

[18]  C. Freeman,et al.  Radiological and pathological response following pre-operative radiotherapy for soft-tissue sarcoma. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[19]  H. Moch,et al.  Relevance of translocation type in myxoid liposarcoma and identification of a novel EWSR1‐DDIT3 fusion , 2007, Genes, chromosomes & cancer.

[20]  L. Mariani,et al.  Myxoid/round cell and pleomorphic liposarcomas , 2007, Cancer.

[21]  P. Åman,et al.  Irradiation of myxoid/round cell liposarcoma induces volume reduction and lipoma-like morphology , 2007, Acta oncologica.

[22]  G. Adelmant,et al.  Human Translocation Liposarcoma-CCAAT/Enhancer Binding Protein (C/EBP) Homologous Protein (TLS-CHOP) Oncoprotein Prevents Adipocyte Differentiation by Directly Interfering with C/EBPβ Function* , 1998, The Journal of Biological Chemistry.

[23]  N. Mandahl,et al.  Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma , 1993, Nature.

[24]  F. Collin,et al.  Evaluation of response after neoadjuvant treatment in soft tissue sarcomas; the European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group (EORTC-STBSG) recommendations for pathological examination and reporting. , 2016, European journal of cancer.